Synapse - Qin Zhou

Results (11)

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: A phase 2 trial with biomarker analyses

Journal Article

Friedman, C. F.; Manning-Geist, B. L.; Zhou, Q.; Soumerai, T.; Holland, A.; Da Cruz Paula, A.; Green, H.; Ozsoy, M. A.; Iasonos, A.; Hollmann, T.; more...
Nature Medicine (2024)

Fulltext@MSK | Save

Pathological, clinical and molecular characterization of large cell neuroendocrine carcinoma (LCNEC) of the urinary tract

Meeting Abstract

Gandhi, J.; Guercio, B.; Mirsadraei, L.; Zhou, Q.; Chen, J. F.; Sarungbam, J.; Chen, Y. B.; Gopalan, A.; Sirintrapun, S. J.; Fine, S.; more...
Laboratory Investigation (2023)

Fulltext@MSK | Save

Associations between circulating proteins and risk of breast cancer by intrinsic subtypes: A Mendelian randomisation analysis

Journal Article

Shu, X.; Zhou, Q.; Sun, X.; Flesaker, M.; Guo, X.; Long, J.; Robson, M. E.; Shu, X. O.; Zheng, W.; Bernstein, J. L.
British Journal of Cancer (2022)

Fulltext@MSK | Save

Myeloablative conditioning and CD34+ selection results in higher chronic-GVHD free/relapse free-survival compared to reduced-intensity conditioning and unmodified graft in patients with AML and MDS > 50 years receiving HLA-matched allogeneic HCT

Meeting Abstract

Barba, P.; Martino, R.; Zhou, Q.; Cho, C.; Castro-Malaspina, H.; Devlin, S.; Esquirol, A.; Giralt, S.; Jakubowski, A.; Lopez-Corral, L.; more...
Bone Marrow Transplantation (2016)

Fulltext@MSK | Save

Undifferentiated endometrial carcinomas: Where do they fit in?

Meeting Abstract

Schiavone, M.; Zivanovic, O.; Zhou, Q.; Soslow, R.; Leitao, M.; Alektiar, K.; Makker, V.; Iasonos, A.; Abu Rustum, N.
Laboratory Investigation (2015)

Fulltext@MSK | Save

Comparison of immunohistochemistry with FISH for detection of TMPRSS2-ERG rearrangement in prostate cancers in African American and Caucasian populations

Meeting Abstract

Elliott, R. M.; Leversha, M. A.; Satagopan, J. M.; Zhou, Q.; Dudas, M.; Chen, Y. B.; Al-Ahmadie, H.; Fine, S.; Tickoo, S.; Eastham, J. A.; more...
Laboratory Investigation (2011)

Fulltext@MSK | Save

Association of NF2 loss and MTOR pathway activation in pleural mesothelioma: Comprehensive genetic analysis of NF2 and immunohistochemistry in 13 cell lines and 53 tumors

Meeting Abstract

Brevet, M.; Bott, M.; Zhou, Q.; Rusch, V.; Ladanyi, M.
Laboratory Investigation (2011)

Fulltext@MSK | Save

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

Journal Article

Bott, M.; Brevet, M.; Taylor, B. S.; Shimizu, S.; Ito, T.; Wang, L.; Creaney, J.; Lake, R. A.; Zakowski, M. F.; Reva, B.; more...
Nature Genetics (2011)

Fulltext@MSK | Save

Increased copy number of TMPRSS2-ERG fusion, but not translocation alone, is associated with aggressive disease in patients treated by prostatectomy

Meeting Abstract

Gopalan, A.; Leversha, M.; Satagopan, J. M.; Zhou, Q. C.; Al-Ahmadie, H. A.; Fine, S. W.; Scardino, P. T.; Tickoo, S. K.; Reuter, V. E.; Gerald, W. L.
Laboratory Investigation (2008)

Fulltext@MSK | Save

Does TMPRSS2-ERG gene fusion status in prostate cancer correlate with Gleason score?

Meeting Abstract

Fine, S. W.; Gopalan, A.; Al-Ahmadie, H. A.; Tickoo, S. K.; Zhou, Q. C.; Satagopan, J. M.; Scardino, P. T.; Gerald, W.; Reuter, V. E.
Laboratory Investigation (2008)

Fulltext@MSK | Save